Jay A Markwalder,James Aaron Balog,Audris Huang,Steven P Seitz
申请号：
US14903091
公开号：
US09895330B2
申请日:
2014.07.10
申请国别(地区):
US
年份:
2018
代理人:
摘要：
There are disclosed compounds of Formula (I) that modulate or inhibit the enzymatic activity of indoleamine 2,3-di-oxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention.
